Back to HomeBeta

ICD-10 Coding for Ductal Carcinoma In Situ (DCIS) of the Breast(D05.1, Z85.3)

Complete ICD-10-CM coding and documentation guide for Ductal Carcinoma In Situ (DCIS) of the Breast. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Intraductal carcinomaNon-invasive breast cancer

Related ICD-10 Code Ranges

Complete code families applicable to Ductal Carcinoma In Situ (DCIS) of the Breast

D05Primary Range

Carcinoma in situ of breast

This range covers all forms of in situ carcinoma of the breast, including ductal and lobular types.

Personal history of malignant neoplasm of breast

Used for patients with a history of breast cancer after complete excision of DCIS.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
D05.1Intraductal carcinoma in situUse when DCIS is confirmed by biopsy without invasive components.
  • Biopsy confirmation of DCIS
  • Nuclear grade and margin status
Z85.3Personal history of malignant neoplasm of breastUse for patients with a history of DCIS after complete excision.
  • Documentation of complete excision of DCIS
  • No residual disease on follow-up

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for ductal carcinoma in situ breast

Essential facts and insights about Ductal Carcinoma In Situ (DCIS) of the Breast

The ICD-10 code for ductal carcinoma in situ of the breast is D05.1, used when DCIS is confirmed by biopsy without invasive components.

Primary ICD-10-CM Codes for ductal carcinoma in situ breast

Intraductal carcinoma in situ
Non-billable Code

Decision Criteria

clinical Criteria

  • Biopsy confirms DCIS without invasion

documentation Criteria

  • Pathology report specifies nuclear grade and margin status

Applicable To

  • DCIS of the breast

Excludes

  • Invasive carcinoma of the breast (C50.-)

Clinical Validation Requirements

  • Biopsy confirmation of DCIS
  • Nuclear grade and margin status

Code-Specific Risks

  • Incorrectly coding suspected DCIS as confirmed

Coding Notes

  • Ensure documentation specifies 'confirmed DCIS' with details on grade and location.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of malignant neoplasm of breast

Z85.3
Use after complete excision of DCIS with no residual disease.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of breast

C50.-
Use C50.- if there is evidence of invasive carcinoma.

Intraductal carcinoma in situ

D05.1
Use D05.1 for active DCIS diagnosis.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Ductal Carcinoma In Situ (DCIS) of the Breast to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D05.1.

Impact

Clinical: Misrepresentation of patient's current treatment status., Regulatory: Potential audit issues due to incorrect coding., Financial: Inaccurate billing and potential claim denials.

Mitigation Strategy

Verify treatment status before coding, Review pathology reports for residual disease

Impact

Reimbursement: Incorrect reimbursement due to inappropriate code usage., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.

Mitigation Strategy

Use symptom codes until biopsy confirms DCIS.

Impact

Discrepancies between imaging findings and pathology reports can trigger audits.

Mitigation Strategy

Ensure all findings are reconciled and documented accurately.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Ductal Carcinoma In Situ (DCIS) of the Breast, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Ductal Carcinoma In Situ (DCIS) of the Breast

Use these documentation templates to ensure complete and accurate documentation for Ductal Carcinoma In Situ (DCIS) of the Breast. These templates include all required elements for proper coding and billing.

Post-lumpectomy follow-up

Specialty: Oncology

Required Elements

  • Pathology results
  • Margin status
  • Follow-up plan

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient status post lumpectomy.
Good Documentation Example
Status post lumpectomy for D05.12 (DCIS left breast). Final pathology: 1.2 cm DCIS, nuclear grade II, margins clear at 2 mm. No invasive component.
Explanation
The good example provides specific details on the pathology findings and margin status, which are critical for accurate coding and follow-up care.

Need help with ICD-10 coding for Ductal Carcinoma In Situ (DCIS) of the Breast? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more